Updates are available Correction dated 2024-09-04
Click to view Correction: https://doi.org/10.1186/s13287-024-03867-1
-
Authors
Zhang, Qixiang
Zeng, Zhu
Wei, Ning
Su, Yueyan
Wang, Jing
Ni, Qi
Wang, Yukai
Yang, Jingwen
Liu, Xiaoyan
Xu, Huanke
Wang, Guangji
Shan, Yunlong
Zhou, Fang
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82073928, 82104184)
Leading technology foundation research project of Jiangsu province (BK20232035, BK20192005)
Haihe Laboratory of Cell Ecosystem Innovation Fund (22HHXBSS00005)
Nanjing Scientific and Technological Special Project for Life and Health (202110006)
the Project of State Key Laboratory of Natural Medicines, China Pharmaceutical University (SKLNMZZ202302)
Fundamental Research Funds for the Central Universities (2632023TD03)
- License Information
-
More Information
Article History
Received: 27 February 2024
Accepted: 23 June 2024
First Online: 2 July 2024
Change Date: 4 September 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13287-024-03867-1
Declarations
:
: All animal procedures were approved by the Committee on the Ethics of Animal Experiments of the China Pharmaceutical University. Project title: In vivo Distribution and Therapeutic Efficacy of hUC-MSCs in Mice with DSS-Induced Colitis. Approved number: SYXK2021-0011. Approved Date: 10th September 2021.
: This manuscript is approved by all authors for publication. I would like to declare on behalf of my co-authors that the work described was original research that has not been published previously, and not under consideration for publication elsewhere, in whole or in part. The materials in this manuscript are not reproduced from other articles. All the authors listed have approved the manuscript that is enclosed.
: The authors declare that they have no competing interests.
